|
Re: New RVX Tweet
|
7
|
Resverlogix Corp.
|
Aug 04, 2020 10:35AM
|
|
Re: AHA Abstracts will be posted Monday 11/9 at 4AM CST
|
7
|
Resverlogix Corp.
|
Nov 09, 2020 10:55AM
|
|
Zenith Epigenetics Announces a Publication Highlighting the Role of ZEN-3694 in Overcoming Resistance to Therapies in mCRPC
|
7
|
Zenith Epigenetics
|
Jun 24, 2021 04:11PM
|
|
Re: Short Interest in RVXCF at new recent high
|
7
|
Resverlogix Corp.
|
Sep 05, 2018 01:24PM
|
|
Re: Zacks SCR Resverlogix Report 11/5/18; Apabetalone: The Last Mile
|
7
|
Resverlogix Corp.
|
Nov 06, 2018 10:11PM
|
|
Re: Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism
|
7
|
Resverlogix Corp.
|
May 24, 2016 10:43PM
|
|
WORLD DIABETES DAY New RVX Blog Post 11/18/15
|
7
|
Resverlogix Corp.
|
Nov 18, 2015 01:18PM
|
|
Re: Total (MACE) Events?
|
7
|
Resverlogix Corp.
|
Jun 18, 2017 03:26PM
|
|
Re: So.....?
|
7
|
Resverlogix Corp.
|
Oct 14, 2017 02:29PM
|
|
Re: DAPA HF
|
7
|
Resverlogix Corp.
|
Sep 05, 2019 07:51PM
|
|
New research report 5/11/16 by Marcel Wijma, Van Leeuwenhoeck Institute
|
7
|
Resverlogix Corp.
|
May 11, 2016 02:30PM
|
|
Re: Sick Patients for Trial Design ... BETonMACE
|
7
|
Resverlogix Corp.
|
Oct 20, 2015 12:01PM
|
|
Re: BETonMACE Enrollment
|
7
|
Resverlogix Corp.
|
Mar 01, 2018 11:38AM
|
|
Re: Bear
|
7
|
Resverlogix Corp.
|
Feb 01, 2020 05:29PM
|
|
Re: Stonegate Capital Partners Initiates Coverage on Resverlogix
|
7
|
Resverlogix Corp.
|
Nov 05, 2015 04:44PM
|
|
2016 Outlook Video
|
7
|
Resverlogix Corp.
|
Feb 17, 2016 04:53PM
|
|
Q2 Resverlogix/Zenith Events
|
7
|
Resverlogix Corp.
|
Apr 12, 2016 12:17PM
|
|
Re: Our own BKC on the webcast
|
7
|
Resverlogix Corp.
|
Feb 05, 2021 06:48AM
|
|
ESC 2019 Symposium: Epigenetics: A new pathway to tackle residual risk?
|
7
|
Resverlogix Corp.
|
Jul 05, 2019 04:20PM
|
|
Goodbye Q3, Hello Q4. RVX in the Next 2 Weeks.
|
7
|
Resverlogix Corp.
|
Sep 28, 2016 09:36AM
|
